Report on investigation of ISO 10993–12 extraction conditions

The international standard ISO 10993-12 describes extraction conditions for generating extracts of medical devices to be used in testing of biological safety. Questions about the adequacy of the extraction conditions (and their variations) for hazard identification drove the development and executio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Regulatory toxicology and pharmacology 2022-06, Vol.131, p.105164-105164, Article 105164
Hauptverfasser: Heise, Theodore, Sawyer, Anita Y., Hirai, Toshiyuki, Schaible, Sandi, Sy, Harmony, Wickramasekara, Samanthi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 105164
container_issue
container_start_page 105164
container_title Regulatory toxicology and pharmacology
container_volume 131
creator Heise, Theodore
Sawyer, Anita Y.
Hirai, Toshiyuki
Schaible, Sandi
Sy, Harmony
Wickramasekara, Samanthi
description The international standard ISO 10993-12 describes extraction conditions for generating extracts of medical devices to be used in testing of biological safety. Questions about the adequacy of the extraction conditions (and their variations) for hazard identification drove the development and execution of a round robin study. Four relevant device materials were each evaluated by four laboratories following an established protocol that specified multiple options of extraction solvent, temperature, duration, and ratio of solvent volume to quantity of test article. The resulting samples were analysed by three instrumental methods to identify and quantify extracted organic and elemental substances; however, quantification was not achieved due to lab resource constraints, and only numbers of compounds were reported. Results showed an increased number of volatile organic compounds extracted with organic solvents; however, no clear effect of varying the other extraction parameters could be discerned. Quantification of a small subset of analytes showed sensitivity that may be adequate for hazard identification. An unplanned post hoc comparison of results across labs showed differing numbers of compounds detected; however, fundamental differences in sample preparation and specific analysis methods as well as lack of quantification render the results poorly suited to either exonerate or indict the adequacy of chemical characterization as practiced by the participating laboratories. •The basis for medical device extraction conditions in ISO 10993–12 is unclear.•Solvent, temperature, duration, and solvent/sample ratio effects were examined.•Organic solvents increased the number of extracted compounds.•Number of compounds differed by lab, likely due to differences in study methods.•Research is needed to identify and reduce true sources of inconsistency.
doi_str_mv 10.1016/j.yrtph.2022.105164
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2647654049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0273230022000514</els_id><sourcerecordid>2647654049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c289t-246c8df1230c77eb146032fb445c608511504a96be523a8fa99ae6d7a1fb62c83</originalsourceid><addsrcrecordid>eNp9kMlKAzEYx4MotlafQJA5epmafZKDiBSXQkFwOYdMJqMp7WRMpsXefAff0CcxXfTo6dv-3_YD4BTBIYKIX0yHq9C1b0MMMU4ZhjjdA30EJc8hlmwf9CEuSI4JhD1wFOMUQoiFKA5BjzAiEMGkD64ebetDl_kmc83Sxs696s6lyNfZ-OkhS-Mk-f78QjizH13QZlM0vqnc2ovH4KDWs2hPdnYAXm5vnkf3-eThbjy6nuQGC9nlmHIjqhqlY0xR2BJRDgmuS0qZ4VAwhBikWvLSMky0qLWU2vKq0KguOTaCDMD5dm4b_Psi3anmLho7m-nG-kVUmNOCMwqpTFKylZrgYwy2Vm1wcx1WCkG1JqemakNOrcmpLbnUdbZbsCjntvrr-UWVBJdbgU1vLp0NKhpnG2MrF6zpVOXdvwt-AHXXfuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2647654049</pqid></control><display><type>article</type><title>Report on investigation of ISO 10993–12 extraction conditions</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Heise, Theodore ; Sawyer, Anita Y. ; Hirai, Toshiyuki ; Schaible, Sandi ; Sy, Harmony ; Wickramasekara, Samanthi</creator><creatorcontrib>Heise, Theodore ; Sawyer, Anita Y. ; Hirai, Toshiyuki ; Schaible, Sandi ; Sy, Harmony ; Wickramasekara, Samanthi</creatorcontrib><description>The international standard ISO 10993-12 describes extraction conditions for generating extracts of medical devices to be used in testing of biological safety. Questions about the adequacy of the extraction conditions (and their variations) for hazard identification drove the development and execution of a round robin study. Four relevant device materials were each evaluated by four laboratories following an established protocol that specified multiple options of extraction solvent, temperature, duration, and ratio of solvent volume to quantity of test article. The resulting samples were analysed by three instrumental methods to identify and quantify extracted organic and elemental substances; however, quantification was not achieved due to lab resource constraints, and only numbers of compounds were reported. Results showed an increased number of volatile organic compounds extracted with organic solvents; however, no clear effect of varying the other extraction parameters could be discerned. Quantification of a small subset of analytes showed sensitivity that may be adequate for hazard identification. An unplanned post hoc comparison of results across labs showed differing numbers of compounds detected; however, fundamental differences in sample preparation and specific analysis methods as well as lack of quantification render the results poorly suited to either exonerate or indict the adequacy of chemical characterization as practiced by the participating laboratories. •The basis for medical device extraction conditions in ISO 10993–12 is unclear.•Solvent, temperature, duration, and solvent/sample ratio effects were examined.•Organic solvents increased the number of extracted compounds.•Number of compounds differed by lab, likely due to differences in study methods.•Research is needed to identify and reduce true sources of inconsistency.</description><identifier>ISSN: 0273-2300</identifier><identifier>EISSN: 1096-0295</identifier><identifier>DOI: 10.1016/j.yrtph.2022.105164</identifier><identifier>PMID: 35381323</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Solvents - chemistry ; Volatile Organic Compounds</subject><ispartof>Regulatory toxicology and pharmacology, 2022-06, Vol.131, p.105164-105164, Article 105164</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c289t-246c8df1230c77eb146032fb445c608511504a96be523a8fa99ae6d7a1fb62c83</citedby><cites>FETCH-LOGICAL-c289t-246c8df1230c77eb146032fb445c608511504a96be523a8fa99ae6d7a1fb62c83</cites><orcidid>0000-0002-0341-0430</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.yrtph.2022.105164$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35381323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heise, Theodore</creatorcontrib><creatorcontrib>Sawyer, Anita Y.</creatorcontrib><creatorcontrib>Hirai, Toshiyuki</creatorcontrib><creatorcontrib>Schaible, Sandi</creatorcontrib><creatorcontrib>Sy, Harmony</creatorcontrib><creatorcontrib>Wickramasekara, Samanthi</creatorcontrib><title>Report on investigation of ISO 10993–12 extraction conditions</title><title>Regulatory toxicology and pharmacology</title><addtitle>Regul Toxicol Pharmacol</addtitle><description>The international standard ISO 10993-12 describes extraction conditions for generating extracts of medical devices to be used in testing of biological safety. Questions about the adequacy of the extraction conditions (and their variations) for hazard identification drove the development and execution of a round robin study. Four relevant device materials were each evaluated by four laboratories following an established protocol that specified multiple options of extraction solvent, temperature, duration, and ratio of solvent volume to quantity of test article. The resulting samples were analysed by three instrumental methods to identify and quantify extracted organic and elemental substances; however, quantification was not achieved due to lab resource constraints, and only numbers of compounds were reported. Results showed an increased number of volatile organic compounds extracted with organic solvents; however, no clear effect of varying the other extraction parameters could be discerned. Quantification of a small subset of analytes showed sensitivity that may be adequate for hazard identification. An unplanned post hoc comparison of results across labs showed differing numbers of compounds detected; however, fundamental differences in sample preparation and specific analysis methods as well as lack of quantification render the results poorly suited to either exonerate or indict the adequacy of chemical characterization as practiced by the participating laboratories. •The basis for medical device extraction conditions in ISO 10993–12 is unclear.•Solvent, temperature, duration, and solvent/sample ratio effects were examined.•Organic solvents increased the number of extracted compounds.•Number of compounds differed by lab, likely due to differences in study methods.•Research is needed to identify and reduce true sources of inconsistency.</description><subject>Solvents - chemistry</subject><subject>Volatile Organic Compounds</subject><issn>0273-2300</issn><issn>1096-0295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlKAzEYx4MotlafQJA5epmafZKDiBSXQkFwOYdMJqMp7WRMpsXefAff0CcxXfTo6dv-3_YD4BTBIYKIX0yHq9C1b0MMMU4ZhjjdA30EJc8hlmwf9CEuSI4JhD1wFOMUQoiFKA5BjzAiEMGkD64ebetDl_kmc83Sxs696s6lyNfZ-OkhS-Mk-f78QjizH13QZlM0vqnc2ovH4KDWs2hPdnYAXm5vnkf3-eThbjy6nuQGC9nlmHIjqhqlY0xR2BJRDgmuS0qZ4VAwhBikWvLSMky0qLWU2vKq0KguOTaCDMD5dm4b_Psi3anmLho7m-nG-kVUmNOCMwqpTFKylZrgYwy2Vm1wcx1WCkG1JqemakNOrcmpLbnUdbZbsCjntvrr-UWVBJdbgU1vLp0NKhpnG2MrF6zpVOXdvwt-AHXXfuA</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Heise, Theodore</creator><creator>Sawyer, Anita Y.</creator><creator>Hirai, Toshiyuki</creator><creator>Schaible, Sandi</creator><creator>Sy, Harmony</creator><creator>Wickramasekara, Samanthi</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0341-0430</orcidid></search><sort><creationdate>202206</creationdate><title>Report on investigation of ISO 10993–12 extraction conditions</title><author>Heise, Theodore ; Sawyer, Anita Y. ; Hirai, Toshiyuki ; Schaible, Sandi ; Sy, Harmony ; Wickramasekara, Samanthi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c289t-246c8df1230c77eb146032fb445c608511504a96be523a8fa99ae6d7a1fb62c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Solvents - chemistry</topic><topic>Volatile Organic Compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heise, Theodore</creatorcontrib><creatorcontrib>Sawyer, Anita Y.</creatorcontrib><creatorcontrib>Hirai, Toshiyuki</creatorcontrib><creatorcontrib>Schaible, Sandi</creatorcontrib><creatorcontrib>Sy, Harmony</creatorcontrib><creatorcontrib>Wickramasekara, Samanthi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Regulatory toxicology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heise, Theodore</au><au>Sawyer, Anita Y.</au><au>Hirai, Toshiyuki</au><au>Schaible, Sandi</au><au>Sy, Harmony</au><au>Wickramasekara, Samanthi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Report on investigation of ISO 10993–12 extraction conditions</atitle><jtitle>Regulatory toxicology and pharmacology</jtitle><addtitle>Regul Toxicol Pharmacol</addtitle><date>2022-06</date><risdate>2022</risdate><volume>131</volume><spage>105164</spage><epage>105164</epage><pages>105164-105164</pages><artnum>105164</artnum><issn>0273-2300</issn><eissn>1096-0295</eissn><abstract>The international standard ISO 10993-12 describes extraction conditions for generating extracts of medical devices to be used in testing of biological safety. Questions about the adequacy of the extraction conditions (and their variations) for hazard identification drove the development and execution of a round robin study. Four relevant device materials were each evaluated by four laboratories following an established protocol that specified multiple options of extraction solvent, temperature, duration, and ratio of solvent volume to quantity of test article. The resulting samples were analysed by three instrumental methods to identify and quantify extracted organic and elemental substances; however, quantification was not achieved due to lab resource constraints, and only numbers of compounds were reported. Results showed an increased number of volatile organic compounds extracted with organic solvents; however, no clear effect of varying the other extraction parameters could be discerned. Quantification of a small subset of analytes showed sensitivity that may be adequate for hazard identification. An unplanned post hoc comparison of results across labs showed differing numbers of compounds detected; however, fundamental differences in sample preparation and specific analysis methods as well as lack of quantification render the results poorly suited to either exonerate or indict the adequacy of chemical characterization as practiced by the participating laboratories. •The basis for medical device extraction conditions in ISO 10993–12 is unclear.•Solvent, temperature, duration, and solvent/sample ratio effects were examined.•Organic solvents increased the number of extracted compounds.•Number of compounds differed by lab, likely due to differences in study methods.•Research is needed to identify and reduce true sources of inconsistency.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>35381323</pmid><doi>10.1016/j.yrtph.2022.105164</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0341-0430</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0273-2300
ispartof Regulatory toxicology and pharmacology, 2022-06, Vol.131, p.105164-105164, Article 105164
issn 0273-2300
1096-0295
language eng
recordid cdi_proquest_miscellaneous_2647654049
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Solvents - chemistry
Volatile Organic Compounds
title Report on investigation of ISO 10993–12 extraction conditions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A50%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Report%20on%20investigation%20of%20ISO%2010993%E2%80%9312%20extraction%20conditions&rft.jtitle=Regulatory%20toxicology%20and%20pharmacology&rft.au=Heise,%20Theodore&rft.date=2022-06&rft.volume=131&rft.spage=105164&rft.epage=105164&rft.pages=105164-105164&rft.artnum=105164&rft.issn=0273-2300&rft.eissn=1096-0295&rft_id=info:doi/10.1016/j.yrtph.2022.105164&rft_dat=%3Cproquest_cross%3E2647654049%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2647654049&rft_id=info:pmid/35381323&rft_els_id=S0273230022000514&rfr_iscdi=true